mesalamine has been researched along with Growth Disorders in 2 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Guidelines for treatment of ulcerative colitis in children have been created by the working group of the Japanese Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Japanese Society for Pediatric Inflammatory Bowel Disease." | 2.43 | [Guidelines for treatment of ulcerative colitis in children]. ( Tomomasa, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomomasa, T | 1 |
| Braegger, CP | 1 |
| Torresani, T | 1 |
| Murch, SH | 1 |
| Savage, MO | 1 |
| Walker-Smith, JA | 1 |
| MacDonald, TT | 1 |
1 review available for mesalamine and Growth Disorders
| Article | Year |
|---|---|
[Guidelines for treatment of ulcerative colitis in children].
Topics: Azathioprine; Child; Colitis, Ulcerative; Contraindications; Cyclosporins; Growth Disorders; Humans; | 2005 |
1 other study available for mesalamine and Growth Disorders
| Article | Year |
|---|---|
Urinary growth hormone in growth-impaired children with chronic inflammatory bowel disease.
Topics: Adolescent; Aminosalicylic Acids; Child; Colitis, Ulcerative; Creatinine; Crohn Disease; Enzyme-Link | 1993 |